GSK

GSK plc, a prominent British multinational pharmaceutical and biotechnology company, was established in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. Operating within the Pharmaceuticals and Healthcare industries, GSK is recognized as the tenth-largest pharmaceutical company globally. With a significant global footprint, the company maintains 237 locations worldwide. GSK's core mission revolves around discovering, developing, manufacturing, and delivering innovative medicines and vaccines. Its research and development efforts are strategically focused on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, and HIV and infectious diseases. The company's extensive product portfolio encompasses specialty medicines, crucial vaccines, and general medicines designed to address a wide spectrum of health conditions. Additionally, GSK offers a robust range of over-the-counter products for everyday health needs, including pain relief, oral care, nutrition, skin health, and gastrointestinal remedies. The company's commitment extends to positively impacting the health of 2.5 billion people by the end of the decade.

GSK's operational strategy emphasizes scientific innovation and patient-centricity. Its product pipeline targets critical conditions such as HIV, various respiratory diseases, cancer, immuno-inflammatory disorders, and viral infections. Beyond specialty treatments, the company provides solutions for central nervous system disorders, metabolic and cardiovascular diseases, dermatological conditions, and rare diseases. The company's dedication to public health is evident in its vaccine development and distribution, aiming for widespread accessibility. GSK's business model involves selling its products through diverse channels, including wholesalers, pharmacies, hospitals, and healthcare professionals globally, ensuring broad market penetration and patient access to its therapeutic innovations.

In July 2024, GSK relocated itsView more...